Suresh Ramalingam tells us what it’s like to become director of Emory Cancer Center and editor of Cancer—on the same day

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

It’s safe to say that July 1 was a better than average day for Suresh S. Ramalingam.

By coincidence, on that day he became the executive director of Winship Cancer Institute of Emory University and editor-in-chief of Cancer, a high-impact journal published by the American Cancer Society.

At Emory, Ramalingam, the center’s deputy director and the PI of the lung cancer SPORE succeeds Walter J. Curran Jr., who stepped down as executive director at Emory to become the global chief medical officer of GenesisCare (The Cancer Letter, Oct. 23, 2020).

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Paul Goldberg
Editor & Publisher

YOU MAY BE INTERESTED IN

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

Paul Goldberg
Editor & Publisher

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.

Login